where's our liver trial....?, page-8

re: where's our liver trial? could this be it?? Redgum, your are correct – the 7.30 report did not provide much to work with trying to find the name of drug or company involved.

In Progen’s annual report there is a segment "Drug Discovery efforts focused on VEGF".
Annual report pg. 14. (For non-shareholders the report is available on-line from: www.progen.com.au)

From the 7.30 Report: “The cancer cells give off a chemical called VEGF, or vascular endothelial growth factor, into the area around the tumour. VEGF attracts blood vessels to grow towards it.
Angiogenesis inhibiting drugs work by getting into the cancer patient's blood stream and binding to the VEGF, mopping it up, preventing the cancer from developing its own blood supply and helping kill the cancer.”